Medpat Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 10.67%
- Profit Growth -155.69%
- Ebitda 138.26%
- Net Worth -9.24%
- Total Assets -8.95%
About Medpat Pharma
Medpat Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2018 (Six years and two months 25 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Malkani, Raajan Kumar, and Saajan Goswami serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U93090UR2018PTC009231
-
Company No.
009231
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Medpat Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Malkani
|
Director | 21-Nov-2018 | Current |
|
Raajan Kumar
|
Director | 21-Nov-2018 | Current |
|
Saajan Goswami
|
Director | 21-Nov-2018 | Current |
Financial Performance of Medpat Pharma.
Medpat Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.67% increase. The company also saw a substantial fall in profitability, with a 155.69% decrease in profit. The company's net worth dipped by a decrease of 9.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medpat Pharma?
Unlock access to Medpat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medpat Pharma?
Medpat Pharma has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medpat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medpat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.